- Phase 3 ELEVATE UC 52 and 12 on course for Q1 2022 topline data readout February 23, 2022 04:05 PM Eastern Standard Time PARK CITY, Utah-(BUSINESS WIRE)-Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2021. Key Program & Corporate [...]The post Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates appeared first on CannabisFN.
Arena Pharmaceuticals is California-based biopharmaceutical company that develops and commercializes therapies for the treatment of immuno-inflammatory diseases.